· ICM Paris Brain Institute · Talk
When to stop immune checkpoint inhibitor for malignant melanoma? Challenges in emulating target trials
Université Paris Cité and Université Sorbonne Paris Nord
We use cookies for analytics.
Université Paris Cité and Université Sorbonne Paris Nord,
1 talk
· ICM Paris Brain Institute · Talk
Université Paris Cité and Université Sorbonne Paris Nord